Ensacove Patient Assistance Program

(ensartinib)

Key Takeaways

  1. Ensacove (ensartinib) is a targeted ALK inhibitor used to treat adults with ALK-positive locally advanced or metastatic non-small cell lung cancer (NSCLC) who have not previously received an ALK inhibitor.
  2. Ensacove is a high-cost specialty cancer medication with no FDA-approved generic alternative currently available in the United States.
  3. Prescription Hope may help eligible patients access the Ensacove patient assistance program, potentially lowering treatment costs for those who qualify.

Introduction

For patients diagnosed with ALK-positive non-small cell lung cancer (NSCLC), targeted therapies have transformed treatment options by addressing the specific genetic changes that drive cancer growth. Ensacove® (ensartinib) is a next-generation ALK inhibitor designed to target tumors containing ALK gene rearrangements, helping slow disease progression and improve treatment outcomes.

Approved by the FDA in 2024, Ensacove offers a first-line treatment option for eligible adults with locally advanced or metastatic ALK-positive NSCLC. Because it is a specialty oncology medication, the cost of treatment can be substantial, leaving many patients searching for affordable ways to access therapy.

The Ensacove patient assistance program and other prescription assistance resources may help eligible patients obtain access to this important targeted cancer treatment while reducing out-of-pocket expenses.

Prescription Hope offers access to affordable medications through patient assistance programs.

 

What Is the Ensacove Patient Assistance Program?

Understanding Prescription Assistance

Dealing with serious conditions such as NSCLC can mean extensive medical treatments, hospital visits, and expensive medication regimens.

Unfortunately, some patients do not have adequate insurance coverage or finances to handle the costs associated with serious medical conditions.

Pharmaceutical manufacturers understand that their specialty medications, such as Ensacove, may be too costly for most patients. Therefore, manufacturers offer patient assistance programs for patients struggling to cover their medication costs.

These programs provide medications at affordable rates to patients who qualify.

Unfortunately, many of them require intensive effort during the application process. When dealing with the stress and burden of treating serious conditions, patients often feel overwhelmed by the patient assistance program application process.

Prescription Hope can help.

How Prescription Hope May Help

Support Navigating Patient Assistance Programs

Getting Ensacove assistance through Prescription Hope is a simple process. Our patient advocates offer prescription assistance services that include completing your patient assistance program forms on your behalf, collecting all documents and signatures, and communicating with healthcare providers and manufacturers.

We advocate on your behalf throughout your application journey, easing the burden and allowing you to focus on your treatment and loved ones.

 

Ongoing Patient Support

Plus, our patient advocates continue to manage your patient assistance program access, taking care of necessary tasks such as refill scheduling, document updates, yearly renewals, and more.

Ensacove Price Comparison

vs

Prescription Hope logo

Estimated Retail Price*

$2,395.20

30-Day Supply

Prescription Hope Price

$70

Per Month, NO Matter The Retail Price

*Source: Drugs.com

Navigating Rare Disease Treatment Costs

All of Prescription Hope’s medication access support services are included in our low service rate of $70.00 per month, per medication.

For those who don’t qualify for their intended program, we continue to search for other ways to save. Those may include substitute medications, discount cards, coupons, and more.

And if we can’t help you save, then you pay nothing!

 

Ensacove Patient Assistance Program Eligibility

Who May Qualify?

Those looking for who qualifies for prescription assistance and more specifically, Ensacove eligibility requirements, can learn the details by enrolling with Prescription Hope.

All programs differ in their requirements; however, each program sets its criteria in several general categories:

Income: All programs maintain their own income threshold requirements.

Insurance: All programs also maintain their own insurance coverage status criteria for qualification.

Prescription: Every patient must maintain a valid prescription for the brand-name medication they wish to qualify for.

U.S. Residency: All patients must be legal U.S. residents to qualify.

 

Simple Enrollment With Expert Support

Getting Started With Enrollment

Looking to apply for Ensacove assistance? Prescription Hope’s enrollment process takes 6 simple steps:

  1. Submit Information: Filling out our online enrollment form only takes a few minutes to complete.
  2. Advocate Contact: Our team of patient advocates will contact you within 1-2 business days after receiving your enrollment form.
  3. Document Collection: After prequalification, we collect necessary documents.
  4. Provider Coordination: We also work with your healthcare provider to secure needed signatures.
  5. Program Submission: Once everything is collected, we submit your application packet to the manufacturer and continue to coordinate with them throughout the process.
  6. Medication Delivery: After a patient receives approval into the program, they typically receive their medication within 2 weeks. All medications ship directly from the manufacturer to their door or doctor’s office.

Prescription Hope is not a pharmacy or manufacturer and therefore does not handle medications at any time.

 

What Is Ensacove?

FDA-Approved Uses

Ensacove is FDA-approved for the treatment of adults with ALK-positive locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumors have been identified using an FDA-approved diagnostic test and who have not previously received an ALK inhibitor.

Healthcare providers may prescribe it for patients with newly diagnosed advanced ALK-positive NSCLC who require first-line targeted treatment.

 

How Ensacove Works

Ensacove contains ensartinib, a second-generation ALK tyrosine kinase inhibitor (TKI).

In ALK-positive lung cancer, abnormal ALK gene rearrangements produce proteins that promote uncontrolled cancer growth. Ensacove blocks ALK signaling, helping to:

  • Slow tumor growth
  • Reduce cancer cell survival
  • Limit disease progression
  • Promote cancer cell death

Because it specifically targets ALK-driven tumors, the medication is considered a precision medicine approach to lung cancer treatment.

 

Benefits of Ensacove

Potential benefits of treatment include:

  • Targeting the underlying ALK driver mutation
  • Slowing progression of ALK-positive NSCLC
  • Providing an oral treatment option taken at home
  • Offering first-line therapy for eligible patients
  • Demonstrating improved progression-free survival compared with crizotinib in clinical studies

In the pivotal eXALT3 trial, the medication demonstrated significantly improved progression-free survival compared with crizotinib in patients with ALK-positive NSCLC.

 

Ensacove Side Effects and Safety Information

The most commonly reported side effects of Ensacove include:

  • Rash
  • Musculoskeletal pain
  • Elevated liver enzymes
  • Constipation
  • Itching
  • Cough
  • Fatigue
  • Peripheral edema
  • Nausea
  • Fever
  • Elevated blood sugar
  • Decreased appetite

Liver Toxicity

Ensacove may cause serious liver problems. Healthcare providers typically monitor liver function tests and bilirubin levels throughout treatment.

Patients should promptly report symptoms such as:

  • Yellowing of the skin or eyes
  • Dark urine
  • Severe fatigue
  • Abdominal pain

Interstitial Lung Disease (ILD) and Pneumonitis

Serious lung inflammation may occur during treatment.

Symptoms may include:

  • New or worsening cough
  • Shortness of breath
  • Difficulty breathing
  • Fever

Prompt medical evaluation is recommended if these symptoms develop.

Bradycardia

Ensacove may slow heart rate and cause symptomatic bradycardia.

Patients should report:

  • Dizziness
  • Fainting
  • Unusual fatigue
  • Irregular heartbeat

Hyperglycemia

Elevated blood sugar levels have been reported during treatment. Patients with diabetes may require closer monitoring.

Muscle Toxicity

Increases in creatine phosphokinase (CPK) and muscle-related side effects may occur.

Patients should report:

  • Muscle pain
  • Muscle weakness
  • Muscle tenderness

Photosensitivity

Ensacove may increase sensitivity to sunlight.

Patients should:

  • Use sunscreen
  • Wear protective clothing
  • Avoid excessive sun exposure

Pregnancy and Breastfeeding

Ensacove may cause fetal harm if used during pregnancy. Patients should discuss contraception requirements and reproductive risks with their healthcare provider before beginning treatment.

Breastfeeding is generally not recommended during treatment and for a period after the final dose.

Drug Interactions

Potential interactions may occur with:

  • Strong CYP3A inhibitors
  • Strong CYP3A inducers
  • Certain heart-rate-lowering medications
  • Other medications that affect liver metabolism

Patients should provide a complete medication list to their healthcare provider before starting treatment.

 

Ensacove Dosing and Administration

How should I take my Ensacove?

Ensacove is:

  • Taken orally as a capsule
  • Typically taken once daily
  • Taken continuously until disease progression or unacceptable toxicity
  • Self-administered at home

Patients may take Ensacove with or without food and should take doses at approximately the same time each day.

Regular monitoring is required throughout treatment.

Be sure to consult your healthcare provider on dosing recommendations and treatment options.

Why Patients Choose Prescription Hope

Access Support for Specialty Oncology Medications

Prescription Hope has offered medication affordability solutions since 2006. Patients across the nation have enjoyed our specialty medication assistance and found peace of mind in our simple service rate of $70.00 per month, per medication.

Simplifying the Assistance Process

We simplify the prescription assistance enrollment process for cancer treatment support. Our Florida-based patient advocates work on your behalf, handling each step with compassion.

Ongoing Patient Advocacy

It doesn’t end there. Our patient-centered medication support continues to bring you access to affordable cancer medications for as long as you are a patient with us. We take care of refill scheduling, document updates, yearly renewals, and more.

Network Access

Our nationwide network has come to include hundreds of pharmaceutical manufacturers and healthcare providers across America.

If you are looking to get affordable Ensacove, be sure to enroll in Prescription Hope to access the Ensacove Patient Assistance Program. Let us help you save on your specialty medication costs today!

 

Frequently Asked Questions

It's Easy!

Submit Enrollment Form

Getting started is free and easy! Simply complete the online enrollment form. 

Receive Welcome Call

An Enrollment Specialist will reach out to you for a personalized welcome call.

We Manage The Process

Your dedicated team manages your account month after month, allowing you to focus on what matters most—your health.

Helpful Articles

Latest News & Stories

Save Money On Your Prescriptions Today!